Healcisio

Healcisio is a healthcare technology startup based in La Jolla, CA, focused on developing AI-based diagnostic tools for healthcare providers and hospitals. The company's core offering is an AI-powered software solution that continuously monitors patient data, including laboratory results, vital signs, medications, and comorbidities, to predict sepsis before obvious clinical manifestations become apparent.

Healcisio's AI model works by employing deep learning techniques, such as artificial neural networks, to analyze over 150 patient variables and identify those at high risk of sepsis. The AI system seamlessly integrates with existing electronic health record interfaces, providing explanatory notifications to care teams when a patient's condition warrants concern, thus enabling timely interventions.

A recent peer-reviewed study published in NPJ Digital Medicine in January 2024 demonstrated that Healcisio's AI model effectively reduced sepsis-related patient mortality by nearly 20% across two emergency departments, with over 6,000 patient encounters analyzed. Additionally, the AI-driven notifications contributed to improvements in the Centers for Medicare & Medicaid Services (CMS) SEP-1 quality measure for sepsis care.

Healcisio's approach sets it apart by addressing technical barriers to seamless clinical intelligence, deploying complex AI models directly onto electronic health records, and fusing data from multiple modalities such as text and wearables. The company has successfully deployed its sepsis AI into clinical use, making it one of the first clinically validated machine-learning solutions for sepsis prediction.